medigraphic.com
ISSN 1561-3054 (Electronic)

2021, Number 2

<< Back Next >>

Rev Cubana Med Trop 2021; 73 (2)

AmpC β-lactamases in Gram-negative bacilli from clinical isolates in a Colombian tertiary hospital

Mora MDP, Torres CMI, Sussman POA

Language: Spanish
References: 24
Page: 1-17
PDF size: 407.96 Kb.


ABSTRACT

Introduction: AmpC β-lactamases are enzymes with hydrolytic activity. They may be either constitutive or inducible. No standardized method is available for their phenotypical determination by international standards. Their detection by molecular biology could be a useful alternative for the surveillance and control of the spread of clones circulating in hospital environments.
Objective: Determine the resistance phenotype and genes expressed in the production of AmpC β-lactamases in Gram-negative bacilli from clinical isolates in a hospital.
Methods: An observational descriptive cross-sectional study was conducted. A total 78 bacterial strains were selected as carriers of AmpC β-lactamases. Disc approximation tests were performed. The strains testing positive were selected for DNA extraction and multiplex PCR for detection of six AmpC gene families. Determination was made of the frequency per sample type, service and comparison with the susceptibility profile.
Results: Of the strains selected with AmpC phenotype, 57.6% (45/78) were considered to be AmpC β-lactamase confirmed cases, due to their positive confirmatory test. The molecular technique used confirmed the presence of AmpC genes in 40% (18/45) of the cases. The gene most commonly obtained was MIR n= 9 (20%), followed by DHA n= 7 (15%).
Conclusions: Timely detection of genes encoding for AmpC β-lactamases makes it possible to set up strategies to prevent plasmid-mediated circulation in hospitals, as well as apply better therapeutic options that do not induce other resistance mechanisms.


REFERENCES

  1. Kohlmann R, Bähr T, Gatermann SG. Species-specific mutation rates for ampC derepression in Enterobacterales with chromosomally encoded inducible AmpC ß-lactamase. J Antimicrob Chemother. 2018;73(6):1530-6.

  2. Rada AM, Hernández-Gómez C, Restrepo E, Villegas MV. Distribución y caracterización molecular de betalactamasas en bacterias gramnegativas en Colombia, 2001-2016. Rev Biomédica. 2019;39(1):199-220.

  3. Ku Y-H, Lee M-F, Chuang Y-C, Yu W-L. Detection of plasmid-mediated ß-Lactamase genes and emergence of a novel AmpC (CMH-1) in Enterobacter cloacae at a medical Center in Southern Taiwan. JCM. 2019;8(1):8.

  4. Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC ß-lactamase genes in clinical isolates by using multiplex PCR. JCM. 2002;40(6):2153-62.

  5. Velandia DPL, Caycedo MIT, Orduz LMC, Quiroga CFP. Determinación de genes que codifican la resistencia de betalactamasas de espectro extendido en bacilos gramnegativos aislados de urocultivos. ISUB. 2016;3(2):107-26.

  6. Ghonaim R, Moaety H. Comparison between Multiplex PCR and Phenotypic Detection Methods for Identifying AmpC ß-lactamases Among Clinical Isolates of Enterobacteriaceae in Zagazig University Hospitals, Egypt. Clin Microbiol 2018, 7:3. Disponible en: http://10.4172/2327-5073.1000313

  7. Ding J, Chen Z, Li Y, Zhang Q, Li X. Detection of integrons in Escherichia coli producing plasmid-mediated AmpC ß-lactamases. Int J Clin Exp Med. 2019;12(2):1690-6.

  8. Chakraborty A, Adhikari P, Shenoy S, Saralaya V. Characterization of plasmid mediated AmpC producing Escherichia coli clinical isolates from a tertiary care hospital in South India. Indian J Pathol Micr. 2014;57(2):255.

  9. Liu X, Liu Y. Detection of plasmid-mediated AmpC ß-lactamase in Escherichia coli. Biomed Rep. 2016;4(6):687-90. Disponible en: http://10.3892/br.2016.661.

  10. Reuland EA, Halaby T, Hays JP, de Jongh DM, Snetselaar HD, Van Keulen M, et al. Plasmid-mediated AmpC: prevalence in community-acquired isolates in Amsterdam, the Netherlands, and risk factors for carriage. PLoS One. 2015;10(1).

  11. Khari FIM, Karunakaran R, Rosli R, Tay ST. Genotypic and phenotypic detection of AmpC ß-lactamases in Enterobacter spp. isolated from a teaching hospital in Malaysia. PloS one. 2016;11(3).

  12. Tamma PD, Doi Y, Bonomo RA, Johnson JK, Simner PJ. A Primer on AmpC ß-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World. Clin Infect Dis. 2019;69(8):1446-55.

  13. Seral C, Gude MJ, Castillo FJ. Emergencia de ß-lactamasas AmpC plasmídicas (pAmpC ó cefamicinasas): origen, importancia, detección y alternativas terapéuticas. Rev Esp Quimioter. 2012;25(2).

  14. Osante NP. Detección y bases genéticas de beta-lactamasas AmpC y carbapenemasas en aislados clínicos y comensales de enterobacterias [Tesis. España: Universidad de La Rioja; 2015.

  15. Ahmed SF, Ali MMM, Mohamed ZK, Moussa TA, Klena JD. Fecal carriage of extended-spectrum ß-lactamases and AmpC-producing Escherichia coli in a Libyan community. Ann Clin Microb Ant. 2014;13(1):22.

  16. Lee C-H, Lee Y-T, Kung C-H, Ku W-W, Kuo S-C, Chen T-L, et al. Risk factors of community-onset urinary tract infections caused by plasmid-mediated AmpC ß-lactamase-producing Enterobacteriaceae. J Microbiol Immunol Infect. 2015;48(3):269-75.

  17. Abdalhamid B, Albunayan S, Shaikh A, Elhadi N, Aljindan R. Prevalence study of plasmid-mediated AmpC ß-lactamases in Enterobacteriaceae lacking inducible ampC from Saudi hospitals. JMM. 2017;66(9):1286-90.

  18. Montaña ELV, Salguero JCS, Torres LFB, Ortega HD. ß-lactamasas AmpC en bacilos gramnegativos aislados en una clínica de tercer nivel. Revista Laboratorio Actual Current Laboratory Journal. 2015;(46):11-9.

  19. Japoni-Nejad A, Ghaznavi-Rad E, van Belkum A. Characterization of plasmid-mediated AmpC and carbapenemases among Iranain nosocomial isolates of Klebsiella pneumoniae using phenotyping and genotyping methods. PHRP. 2014;5(6):333-8.

  20. Palmieri M, Schicklin S, Pelegrin AC, Chatellier S, Franceschi C, Mirande C, et al. Phenotypic and genomic characterization of AmpC-producing Klebsiella pneumoniae from Korea. Ann Lab Med. 2018;38(4):367-70.

  21. Wassef M, Behiry I, Younan M, El Guindy N, Mostafa S, Abada E. Genotypic identification of AmpC ß-lactamases production in gramnegative Bacilli isolates. JJM. 2014;7(1).

  22. Coudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. JCM. 2000;38(5):1791-6.

  23. Kazi M, Ajbani K, Tornheim JA, Shetty A, Rodrigues C. Multiplex PCR to detect pAmpC ß-lactamases among enterobacteriaceae at a tertiary care laboratory in Mumbai, India. Microbiology. 2018;165(2):246-50.

  24. Zorgani A, Daw H, Sufya N, Bashein A, Elahmer O, Chouchani C. Co-Occurrence of Plasmid-Mediated AmpC ß-Lactamase Activity Among Klebsiella pneumoniae and Escherichia coli. TOMICROJ. 2017;11:195.




2020     |     www.medigraphic.com